UnitedHealth Group Optumrx — Investment & Other Income increased by 6.3% to $51.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 56.8%, from $118.00M to $51.00M. Over 3 years (FY 2021 to FY 2024), Optumrx — Investment & Other Income shows an upward trend with a 21.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher income reflects effective cash management or favorable market returns, though it is secondary to core operational performance.
Non-operating income derived from the investment of cash reserves and other ancillary activities within the pharmacy ben...
Standard across large healthcare segments that maintain significant working capital and investment portfolios.
unh_segment_optum_rx_investment_and_other_income| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $73.00M | $7.00M | $63.00M | $1.00M | $6.00M | $18.00M | $37.00M | $46.00M | $46.00M | $51.00M | $49.00M | $58.00M | $60.00M | $118.00M | $78.00M | $47.00M | $48.00M | $51.00M |
| QoQ Change | — | -90.4% | +800.0% | -98.4% | +500.0% | +200.0% | +105.6% | +24.3% | +0.0% | +10.9% | -3.9% | +18.4% | +3.4% | +96.7% | -33.9% | -39.7% | +2.1% | +6.3% |
| YoY Change | — | — | — | — | -91.8% | +157.1% | -41.3% | >999% | +666.7% | +183.3% | +32.4% | +26.1% | +30.4% | +131.4% | +59.2% | -19.0% | -20.0% | -56.8% |
We use cookies for analytics. See our Privacy and Cookie Policy.